Page 9 - Research Models News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rhenman & Partners Asset Management AB trimmed its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 13.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 38,000 shares of the medical research company’s stock after […]

Qtron Investments LLC boosted its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 38.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,149 shares of the medical research company’s stock after acquiring an additional 596 shares during the period. […]

Charles River Laboratories International (NYSE:CRL – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Saturday. A number of other equities analysts have also recently commented on CRL. Citigroup lifted their price objective on shares of Charles River Laboratories […]

StockNews.com upgraded shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a hold rating to a buy rating in a research note released on Friday morning. Other equities analysts have also recently issued research reports about the stock. Citigroup raised their target price on shares of Charles River Laboratories International from $215.00 to […]

AMG National Trust Bank lessened its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 1.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,654 shares of the medical research company’s stock after selling 55 shares […]